Report Detail
Global Dry Eye Drugs Market Insights, Forecast to 2025
- RnM3283015 |
- 08 April, 2019 |
- Global |
- 117 Pages |
- QYResearch |
- Pharma & Healthcare
Dry eye syndrome (DES), also known as keratoconjunctivitis sicca (KCS), is the condition of having dry eyes. Other associated symptoms include irritation, redness, discharge, and easily fatigued eyes. Blurred vision may also occur. The symptoms can range from mild and occasional to severe and continuous. Scarring of the cornea may occur in some cases without treatment.
The classification of Dry Eye Drugs includes Artificial Tears, Anti-inflammatory drugs and other, and the proportion of Artificial Tears in 2017 is about 89%.
North America is the largest consumption place, with a consumption market share nearly 40% in 2017. Following North America, Asia Pacific is the second largest consumption place with the consumption market share of 25%.
The global Dry Eye Drugs market is valued at 5350 million US$ in 2018 and will reach 11800 million US$ by the end of 2025, growing at a CAGR of 12.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Dry Eye Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Dry Eye Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Dry Eye Drugs in these regions.
This research report categorizes the global Dry Eye Drugs market by top players/brands, region, type and end user. This report also studies the global Dry Eye Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Allergan
Novartis AG
Valeant Pharmaceuticals
Santen Pharma
Shire
Johnson & Johnson
United Laboratories
Senju Pharmaceutical
Jianfeng Group
Eusan GMBH
Market size by Product
Artificial Tears
Anti-inflammatory Drugs
Other
Market size by End User
Hospital
Drug Stores
Online Pharmacies
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Dry Eye Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Dry Eye Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Dry Eye Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Dry Eye Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Dry Eye Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Dry Eye Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Dry Eye Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Dry Eye Drugs Market Size Growth Rate by Product
- 1.4.2 Artificial Tears
- 1.4.3 Anti-inflammatory Drugs
- 1.4.4 Other
- 1.5 Market by End User
- 1.5.1 Global Dry Eye Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital
- 1.5.3 Drug Stores
- 1.5.4 Online Pharmacies
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Dry Eye Drugs Market Size
- 2.1.1 Global Dry Eye Drugs Revenue 2014-2025
- 2.1.2 Global Dry Eye Drugs Sales 2014-2025
- 2.2 Dry Eye Drugs Growth Rate by Regions
- 2.2.1 Global Dry Eye Drugs Sales by Regions
- 2.2.2 Global Dry Eye Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Dry Eye Drugs Sales by Manufacturers
- 3.1.1 Dry Eye Drugs Sales by Manufacturers
- 3.1.2 Dry Eye Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Dry Eye Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Dry Eye Drugs Revenue by Manufacturers
- 3.2.1 Dry Eye Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Dry Eye Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Dry Eye Drugs Price by Manufacturers
- 3.4 Dry Eye Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Dry Eye Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Dry Eye Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Dry Eye Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Dry Eye Drugs Sales by Product
- 4.2 Global Dry Eye Drugs Revenue by Product
- 4.3 Dry Eye Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Dry Eye Drugs Breakdown Data by End User
6 North America
- 6.1 North America Dry Eye Drugs by Countries
- 6.1.1 North America Dry Eye Drugs Sales by Countries
- 6.1.2 North America Dry Eye Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Dry Eye Drugs by Product
- 6.3 North America Dry Eye Drugs by End User
7 Europe
- 7.1 Europe Dry Eye Drugs by Countries
- 7.1.1 Europe Dry Eye Drugs Sales by Countries
- 7.1.2 Europe Dry Eye Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Dry Eye Drugs by Product
- 7.3 Europe Dry Eye Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Dry Eye Drugs by Countries
- 8.1.1 Asia Pacific Dry Eye Drugs Sales by Countries
- 8.1.2 Asia Pacific Dry Eye Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Dry Eye Drugs by Product
- 8.3 Asia Pacific Dry Eye Drugs by End User
9 Central & South America
- 9.1 Central & South America Dry Eye Drugs by Countries
- 9.1.1 Central & South America Dry Eye Drugs Sales by Countries
- 9.1.2 Central & South America Dry Eye Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Dry Eye Drugs by Product
- 9.3 Central & South America Dry Eye Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Dry Eye Drugs by Countries
- 10.1.1 Middle East and Africa Dry Eye Drugs Sales by Countries
- 10.1.2 Middle East and Africa Dry Eye Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Dry Eye Drugs by Product
- 10.3 Middle East and Africa Dry Eye Drugs by End User
11 Company Profiles
- 11.1 Allergan
- 11.1.1 Allergan Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Allergan Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Allergan Dry Eye Drugs Products Offered
- 11.1.5 Allergan Recent Development
- 11.2 Novartis AG
- 11.2.1 Novartis AG Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Novartis AG Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Novartis AG Dry Eye Drugs Products Offered
- 11.2.5 Novartis AG Recent Development
- 11.3 Valeant Pharmaceuticals
- 11.3.1 Valeant Pharmaceuticals Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Valeant Pharmaceuticals Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Valeant Pharmaceuticals Dry Eye Drugs Products Offered
- 11.3.5 Valeant Pharmaceuticals Recent Development
- 11.4 Santen Pharma
- 11.4.1 Santen Pharma Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Santen Pharma Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Santen Pharma Dry Eye Drugs Products Offered
- 11.4.5 Santen Pharma Recent Development
- 11.5 Shire
- 11.5.1 Shire Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Shire Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Shire Dry Eye Drugs Products Offered
- 11.5.5 Shire Recent Development
- 11.6 Johnson & Johnson
- 11.6.1 Johnson & Johnson Company Details
- 11.6.2 Company Business Overview
- 11.6.3 Johnson & Johnson Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.6.4 Johnson & Johnson Dry Eye Drugs Products Offered
- 11.6.5 Johnson & Johnson Recent Development
- 11.7 United Laboratories
- 11.7.1 United Laboratories Company Details
- 11.7.2 Company Business Overview
- 11.7.3 United Laboratories Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.7.4 United Laboratories Dry Eye Drugs Products Offered
- 11.7.5 United Laboratories Recent Development
- 11.8 Senju Pharmaceutical
- 11.8.1 Senju Pharmaceutical Company Details
- 11.8.2 Company Business Overview
- 11.8.3 Senju Pharmaceutical Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.8.4 Senju Pharmaceutical Dry Eye Drugs Products Offered
- 11.8.5 Senju Pharmaceutical Recent Development
- 11.9 Jianfeng Group
- 11.9.1 Jianfeng Group Company Details
- 11.9.2 Company Business Overview
- 11.9.3 Jianfeng Group Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.9.4 Jianfeng Group Dry Eye Drugs Products Offered
- 11.9.5 Jianfeng Group Recent Development
- 11.10 Eusan GMBH
- 11.10.1 Eusan GMBH Company Details
- 11.10.2 Company Business Overview
- 11.10.3 Eusan GMBH Dry Eye Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.10.4 Eusan GMBH Dry Eye Drugs Products Offered
- 11.10.5 Eusan GMBH Recent Development
12 Future Forecast
- 12.1 Dry Eye Drugs Market Forecast by Regions
- 12.1.1 Global Dry Eye Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Dry Eye Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Dry Eye Drugs Market Forecast by Product
- 12.2.1 Global Dry Eye Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Dry Eye Drugs Revenue Forecast by Product 2019-2025
- 12.3 Dry Eye Drugs Market Forecast by End User
- 12.4 North America Dry Eye Drugs Forecast
- 12.5 Europe Dry Eye Drugs Forecast
- 12.6 Asia Pacific Dry Eye Drugs Forecast
- 12.7 Central & South America Dry Eye Drugs Forecast
- 12.8 Middle East and Africa Dry Eye Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Dry Eye Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Dry Eye Drugs . Industry analysis & Market Report on Dry Eye Drugs is a syndicated market report, published as Global Dry Eye Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Dry Eye Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
